weight-loss drugs
Scope
Date
~
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Micron overtakes SK Hynix in shrinking DRAM market
Micron Technology Inc., the world’s third-largest DRAM maker, raised its share in the shrinking DRAM market in the first quarter, with a milde...
May 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Pension funds
Korea's NPS maintains good grade despite heavy losses: finance ministry
National Pension Service (NPS) of South Korea, the world’s third-largest pension fund with 939 trillion won ($713 billion) in assets as of end...
May 23, 2023 (Gmt+09:00)
-
Capital raising
CJ Bioscience conducts paid-in capital increase of $50 mn
South Korea's CJ Bioscience Inc., a pharmaceutical company specializing in intestinal microorganisms called microbiomes, will conduct a paid-in capi...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
-
Earnings
KEPCO vows to save $19 bn in 5 yrs; CEO offers to resign over swelling losses
South Korea’s state-run utility monopoly Korea Electric Power Corp. (KEPCO) on Friday vowed to save nearly 26 trillion won ($19.5 billion) ove...
May 12, 2023 (Gmt+09:00)
-
Earnings
Lotte Chemical projects recovery in Q2 after 4th consecutive loss in Q1
Lotte Chemical Corp. suffered its fourth consecutive operating loss in the first quarter due to a prolonged petrochemical slowdown amid the global e...
May 11, 2023 (Gmt+09:00)
-
Economy
S.Korea’s chronic disease: Decline in youth employment
The number of young workers in South Korea fell for a sixth straight month in April to its lowest point in more than two years, deepening concerns t...
May 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Real estate
Seoul advised to prepare exit plans for real estate funds
Global real estate investment funds managed by South Korean financial services firms have swelled by more than 14 times to 72 trillion won ($5.4 bil...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel
South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...
May 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem in talks with Glenwood to sell off diagnostics unit
LG Chem Ltd. is slated for exclusive talks with Seoul-based Glenwood Private Equity to sell off its in vitro diagnostics business, according to biop...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to invest $1.8 billion, seeks M&As for inorganic growth
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, plans to spend 2.4 trillion won ($1.8 billion) over the next five years and...
Apr 28, 2023 (Gmt+09:00)
-
Earnings
Samsung bets on H2 recovery with heavy spending after record chip losses
Samsung Electronics Co. on Thursday reported its worst quarterly loss for its semiconductor business, but echoed the widely held industry view that ...
Apr 27, 2023 (Gmt+09:00)
-
Earnings
SK Hynix expects second-half market recovery after record Q1 loss
SK Hynix Inc., the world’s second-largest memory chipmaker, said on Wednesday it expects the global semiconductor market to rebound in the sec...
Apr 26, 2023 (Gmt+09:00)
-
Earnings
S.Korea’s Woori Financial profit up on interest rate margins
Woori Financial Group, South Korea’s fourth-largest financial holding company, logged growth in a quarterly net profit as larger interest rate...
Apr 25, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GeneOne Life Science gets patent for coated microneedle tech in China
South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Pr...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, UK firm to jointly develop autoimmune disease drug
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...
Apr 18, 2023 (Gmt+09:00)
-
E-commerce
Luxury fashion platform Balaan faces thinning coffers amid mounting loss
Concerns are growing about the financial health of South Korean luxury fashion e-commerce platform operator Balaan Co. after its net loss doubled on...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea sees release of generic diabetes drugs after Forxiga patent expires
South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...
Apr 11, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Markets
Korean won at 1-yr low vs yen; end of boon for exporters
The South Korean won has extended its losses against the yen, with the Japanese currency highly sought after as a safe haven asset in the wobbly fin...
Apr 07, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to launch new diabetes combination drug Zemidapa
South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...
Apr 04, 2023 (Gmt+09:00)
-
Korean stock market
S.Korea's tech special IPOs face criticism on poor earnings of ventures
Around 200 South Korean ventures have debuted on the country’s secondary Kosdaq market through the technology special listing program since 20...
Apr 03, 2023 (Gmt+09:00)
-
E-commerce
Kurly seeks fresh funding at half its peak valuation
Kurly Inc., South Korea’s leading food delivery platform, has embarked on a new funding round to raise 100 billion won ($76 million) at about ...
Apr 03, 2023 (Gmt+09:00)
-
Korean stock market
VIP Asset’s new mutual fund to forgo operating fees if it posts losses
VIP Asset Management Co., a leading South Korean asset manager, said on Friday it is launching a new mutual fund, and its managers won’t take ...
Mar 31, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand